Paragraph 40
The licence holder must not publish any advertisement, catalogue, or circular relating to a special medicinal product F1or EAMS medicinal product or make any representations in respect of that product.
Annotations
Textual amendments
- F1
Words in Sch. 4 para. 40 inserted (15.4.2022) by The Human Medicines (Amendments Relating to the Early Access to Medicines Scheme) Regulations 2022 (S.I. 2022/352), regs. 1(2), 14(8) (with reg. 19)